Introducere

Această pagină oferă o analiză cuprinzătoare a istoricului cunoscut al tranzacțiilor privilegiate a Fenimore Christopher R.. Insiders sunt ofițeri, directori sau investitori importanți într-o companie. Este ilegal ca persoanele din interior să facă tranzacții în companiile lor pe baza unor informații specifice, nepublice. Acest lucru nu înseamnă că este ilegal pentru ei să facă tranzacții în propriile companii. Cu toate acestea, ei trebuie să raporteze toate tranzacțiile către SEC printr-un Formular 4. În ciuda acestor restricții, cercetările academice sugerează că persoanele din interior - în general - tind să depășească piața în propriile companii.

Rentabilitatea medie comercială

Rentabilitatea medie a comerțului este randamentul mediu al tuturor achizițiilor de pe piața deschisă efectuate de persoane din interior în ultimii trei ani. Pentru a calcula acest lucru, examinăm fiecare achiziție neplanificată pe piață deschisă făcută de către insider, excluzând toate tranzacțiile care au fost marcate ca parte a unui plan de tranzacționare 10b5-1. Apoi calculăm performanța medie a acelor tranzacții pe 3, 6 și 12 luni, făcând o medie a fiecărei durate pentru a genera o valoare finală a performanței pentru fiecare tranzacție. În cele din urmă, facem o medie a tuturor valorilor de performanță pentru a calcula o valoare de performanță pentru persoana din interior. Această listă include doar persoane din interior care au efectuat cel puțin trei tranzacții în ultimii doi ani.

Dacă profitabilitatea acestei tranzacții este „N/A”, atunci acesta fie nu a făcut nicio achiziție pe piața deschisă în ultimii trei ani, fie tranzacțiile pe care le-au făcut sunt prea recente pentru a calcula o măsură de performanță fiabilă.

Frecvența actualizării: zilnic

Consultați lista celor mai profitabili comercianți din interior.

Companii cu poziții din interior raportate

Înregistrările SEC indică faptul că Fenimore Christopher R. a raportat participații sau tranzacții în următoarele companii:

Securitate Titlu Ultimele participații raportate
US:REGN / Regeneron Pharmaceuticals, Inc. EVP Finance CFO 18.300
Cum se interpretează diagramele

Următoarele diagrame arată performanța acțiunilor de valori mobiliare ulterioare fiecărei tranzacții neplanificate pe piață deschisă efectuată de Fenimore Christopher R.. Comerțurile neplanificate sunt tranzacții care nu au fost efectuate ca parte a unui plan de tranzacționare 10b5-1. Performanța acțiunilor este reprezentată ca variație procentuală cumulată a prețului acțiunilor. De exemplu, dacă o tranzacție privilegiată a fost efectuată la 1 ianuarie 2019, graficul va afișa modificarea procentuală zilnică a titlului până în prezent. Dacă prețul acțiunilor ar merge de la 10 USD la 15 USD în acest timp, modificarea procentuală cumulativă a prețului acțiunilor ar fi de 50%. O modificare a prețului de la 10 USD la 20 USD ar fi 100%, iar o modificare a prețului de la 10 USD la 5 USD ar fi -50%.

În cele din urmă, încercăm să determinăm cât de strâns se corelează tranzacțiile insider-ului cu randamentele în exces (pozitive sau negative) ale prețului acțiunilor, pentru a vedea dacă insider-ul își programează tranzacțiile pentru a profita de informațiile privilegiate. Luați în considerare situația în care un insider făcea asta. În această situație, ne-am aștepta fie la (a) randamente pozitive după achiziții, fie (b) la profituri negative după vânzare. În cazul punctului (a), graficul CUMPĂRĂRI ar arăta o serie de curbe în pantă ascendentă, indicând randamente pozitive după fiecare tranzacție de cumpărare. În cazul (b), graficul VÂNZARE ar arăta o serie de curbe înclinate în jos, indicând randamente negative după fiecare tranzacție de vânzare.

Cu toate acestea, acest lucru în sine nu este suficient pentru a trage concluzii. Dacă, de exemplu, prețul acțiunilor companiei a fost într-o creștere neciclică de-a lungul multor ani, atunci ne-am aștepta ca toate parcelele post-cumpărare să fie în pantă ascendentă. De asemenea, scăderile non-ciclice de-a lungul multor ani ar avea ca rezultat o pantă descendentă post-tranzacționare. Niciunul dintre aceste grafice nu ar sugera activitate de tranzacționare a informațiilor privilegiate.

Cel mai puternic indicator ar fi o situație în care prețul acțiunilor a fost extrem de ciclic, și au existat atât semnale pozitive în graficul CUMPĂRARE, cât și grafice negative pe graficul VÂNZARE. Această situație ar sugera foarte mult un insider care a programat tranzacțiile în avantajul lor financiar.

Istoricul tranzacțiilor privilegiate

Acest tabel arată lista completă a tranzacțiilor privilegiate efectuate de Fenimore Christopher R., astfel cum a fost dezvăluită Comisiei pentru Bursa de Valori Valori (SEC).

Data fișierului Tran Data Formă Ticker Securitate Cod 10b5-1 Acțiuni Acțiuni rămase La sută
Schimbare
Acțiune
Preț
Tran
Valoare
Rămas
Valoare
2025-12-09 2025-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -992 18.300 -5,14 712,94 -707.236 13.046.802
2025-12-09 2025-12-05 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 3.027 19.292 18,61
2024-12-18 2024-12-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -491 16.265 -2,93 730,81 -358.828 11.886.625
2024-12-10 2024-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -1.140 16.756 -6,37 787,00 -897.180 13.186.972
2024-12-10 2024-12-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 2.591 17.896 16,93
2024-08-29 2024-08-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -200 25 -88,89 1.206,67 -241.334 30.167
2024-08-29 2024-08-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -235 225 -51,09 1.205,67 -283.332 271.276
2024-08-29 2024-08-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -200 25 -88,89 1.206,70 -241.340 30.168
2024-08-29 2024-08-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -236 225 -51,19 1.205,67 -284.538 271.276
2024-08-29 2024-08-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -450 0 -100,00 1.206,15 -542.768
2024-08-29 2024-08-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -928 450 -67,34 1.205,49 -1.118.695 542.470
2024-08-29 2024-08-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -2.237 1.378 -61,88 1.204,71 -2.694.936 1.660.090
2024-08-29 2024-08-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -200 0 -100,00 1.206,30 -241.260
2024-08-29 2024-08-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -766 200 -79,30 1.205,44 -923.367 241.088
2024-08-29 2024-08-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -228 966 -19,10 1.204,79 -274.692 1.163.827
2024-02-12 2024-02-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -600 14.372 -4,01 955,00 -573.000 13.725.260
2024-02-12 2024-02-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.100 14.972 -6,84 954,57 -1.050.027 14.291.822
2024-02-12 2024-02-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.342 16.072 -7,71 953,47 -1.279.557 15.324.170
2024-02-12 2024-02-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.046 17.414 -5,67 952,62 -996.441 16.588.925
2024-02-12 2024-02-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -487 18.460 -2,57 951,39 -463.327 17.562.659
2024-02-12 2024-02-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -344 18.947 -1,78 950,49 -326.969 18.008.934
2024-01-25 2024-01-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -3.583 19.291 -15,66 948,50 -3.398.476 18.297.514
2024-01-25 2024-01-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5.000 22.874 27,97 399,66 1.998.300 9.141.823
2024-01-25 2024-01-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -3.986 17.874 -18,23 948,50 -3.780.721 16.953.489
2024-01-25 2024-01-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5.000 21.860 29,66 555,67 2.778.350 12.146.946
2024-01-04 2024-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -3.469 16.860 -17,06 912,30 -3.164.769 15.381.378
2024-01-04 2024-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5.000 20.329 32,62 399,66 1.998.300 8.124.688
2024-01-04 2024-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -4.043 15.329 -20,87 912,30 -3.688.429 13.984.647
2024-01-04 2024-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5.000 19.372 34,79 555,67 2.778.350 10.764.439
2023-12-29 2023-12-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.448 14.372 -14,55 856,71 -2.097.226 12.312.636
2023-12-26 2023-12-22 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -250 16.820 -1,46 846,27 -211.568 14.234.261
2023-12-26 2023-12-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.224 17.070 -6,69 844,09 -1.033.166 14.408.616
2023-12-26 2023-12-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -456 18.294 -2,43 843,79 -384.768 15.436.294
2023-12-14 2023-12-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -2.552 18.750 -11,98 856,71 -2.186.324 16.063.312
2023-12-12 2023-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -260 21.302 -1,21 844,09 -219.463 17.980.805
2023-12-12 2023-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -1.276 21.562 -5,59 844,09 -1.077.059 18.200.269
2023-12-12 2023-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 2.370 22.838 11,58
2023-12-12 2023-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -474 20.468 -2,26 843,79 -399.956 17.270.694
2023-08-25 2023-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -5.198 20.942 -19,89 842,66 -4.380.147 17.646.986
2023-08-25 2023-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 7.000 26.140 36,57 399,66 2.797.620 10.447.112
2023-03-27 2023-03-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.192 18.409 -10,64 806,47 -1.767.782 14.846.306
2023-02-07 2023-02-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -3.286 20.295 -13,93 774,29 -2.544.317 15.714.216
2023-02-07 2023-02-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5.000 23.581 26,91 270,43 1.352.150 6.377.010
2022-12-20 2022-12-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 1.926 18.581 11,56
2022-12-13 2022-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -247 16.655 -1,46 753,28 -186.060 12.545.878
2022-12-13 2022-10-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
G - Gift 435 460 1.740,00
2022-12-13 2022-10-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
G - Gift 436 461 1.744,00
2022-12-13 2022-10-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
G - Gift -871 0 -100,00
2022-10-07 2022-10-05 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.844 16.425 -10,09 749,00 -1.381.156 12.302.325
2022-10-05 2022-10-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3.346 18.269 -15,48 724,00 -2.422.504 13.226.756
2022-04-11 2022-04-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise -2.450 10.000 -19,68
2022-04-11 2022-04-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise -5.000 5.000 -50,00
2022-04-11 2022-04-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -3.451 26.615 -11,48 736,21 -2.540.661 19.594.229
2022-04-11 2022-04-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5.000 30.066 19,95 270,43 1.352.150 8.130.748
2022-04-11 2022-04-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -2.155 25.066 -7,92 736,21 -1.586.533 18.453.840
2022-04-11 2022-04-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2.450 27.221 9,89 555,67 1.361.392 15.125.893
2022-04-01 2022-03-31 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise -2.000 12.450 -13,84
2022-04-01 2022-03-31 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise -10.000 10.000 -50,00
2022-04-01 2022-03-31 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -6.857 24.771 -21,68 700,99 -4.806.688 17.364.223
2022-04-01 2022-03-31 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 10.000 31.628 46,24 270,43 2.704.300 8.553.160
2022-04-01 2022-03-31 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -1.797 21.628 -7,67 700,99 -1.259.679 15.161.012
2022-04-01 2022-03-31 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2.000 23.425 9,33 555,67 1.111.340 13.016.570
2021-12-14 2021-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -270 21.122 -1,26 664,34 -179.372 14.032.189
2021-12-10 2021-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
A - Award 7.941 7.941
2021-12-10 2021-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 1.859 21.392 9,52
2021-08-25 2021-08-20 4/A REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes X -8.719 19.020 -31,43 664,85 -5.796.827 12.645.447
2021-08-24 2021-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -14 27.739 -0,05 665,21 -9.313 18.452.260
2021-08-24 2021-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -70 27.753 -0,25 663,05 -46.414 18.401.627
2021-08-24 2021-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1 27.823 0,00 662,78 -663 18.440.528
2021-08-24 2021-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -88 27.824 -0,32 661,89 -58.246 18.416.427
2021-08-24 2021-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -23 27.912 -0,08 660,33 -15.188 18.431.131
2021-08-24 2021-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -9 27.935 -0,03 659,33 -5.934 18.418.384
2021-08-24 2021-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4.576 27.944 -14,07 655,00 -2.997.280 18.303.320
2021-08-24 2021-08-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -13.500 0 -100,00
2021-08-24 2021-08-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 13.500 32.520 70,98 179,13 2.418.255 5.825.308
2020-12-11 2020-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
A - Award 10.000 10.000
2020-12-11 2020-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 1.750 21.102 9,04
2020-12-11 2020-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 969 19.352 5,27
2020-12-11 2020-09-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
G - Gift 25 25
2020-12-11 2020-09-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
G - Gift 25 25
2020-12-11 2020-09-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
G - Gift -50 0 -100,00
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -11 17.501 -0,06 658,00 -7.238 11.515.658
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -82 17.512 -0,47 647,79 -53.119 11.344.098
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -155 17.594 -0,87 646,82 -100.257 11.380.151
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -72 17.749 -0,40 645,33 -46.464 11.453.962
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -303 17.821 -1,67 644,57 -195.305 11.486.882
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -691 18.124 -3,67 643,49 -444.652 11.662.613
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -676 18.815 -3,47 642,39 -434.256 12.086.568
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -855 19.491 -4,20 641,58 -548.551 12.505.036
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -113 20.346 -0,55 640,61 -72.389 13.033.851
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -75 20.459 -0,37 639,64 -47.973 13.086.395
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -306 20.534 -1,47 638,51 -195.384 13.111.164
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -154 20.840 -0,73 637,88 -98.234 13.293.419
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -216 20.994 -1,02 636,56 -137.497 13.363.941
2020-07-22 2020-07-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -10.000 13.500 -42,55
2020-07-22 2020-07-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Incentive Stock Option (right to buy)
M - Exercise -2.224 0 -100,00
2020-07-22 2020-07-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2.224 21.210 11,71 52,03 115.715 1.103.556
2020-07-22 2020-07-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes X -6.291 18.986 -24,89 655,57 -4.124.191 12.446.652
2020-07-22 2020-07-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 10.000 25.277 65,46 179,13 1.791.300 4.527.869
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -294 15.277 -1,89 596,36 -175.330 9.110.592
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -403 15.571 -2,52 595,50 -239.986 9.272.530
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -747 15.974 -4,47 594,35 -443.979 9.494.147
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -109 16.721 -0,65 593,25 -64.664 9.919.733
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -214 16.830 -1,26 592,20 -126.731 9.966.726
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -233 17.044 -1,35 591,61 -137.845 10.083.401
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -153 17.277 -0,88 590,70 -90.377 10.205.524
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -147 17.430 -0,84 588,80 -86.554 10.262.784
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -373 17.577 -2,08 587,55 -219.156 10.327.366
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -413 17.950 -2,25 586,54 -242.241 10.528.393
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -130 18.363 -0,70 585,76 -76.149 10.756.311
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -99 18.493 -0,53 584,62 -57.877 10.811.378
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -111 18.592 -0,59 583,06 -64.720 10.840.252
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -18 18.703 -0,10 582,69 -10.488 10.898.051
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -112 18.721 -0,59 581,40 -65.117 10.884.389
2020-06-17 2020-06-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -7.226 0 -100,00
2020-06-17 2020-06-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Incentive Stock Option (right to buy)
M - Exercise -2.180 0 -100,00
2020-06-17 2020-06-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2.180 18.833 13,09 30,63 66.773 576.855
2020-06-17 2020-06-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes X -3.670 16.653 -18,06 587,90 -2.157.593 9.790.299
2020-06-17 2020-06-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 7.226 20.323 55,17 52,03 375.969 1.057.406
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Incentive Stock Option (right to buy)
M - Exercise X -1.200 2.180 -35,50
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -68 13.097 -0,52 497,99 -33.863 6.522.175
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -37 13.165 -0,28 494,16 -18.284 6.505.616
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -174 13.202 -1,30 493,24 -85.824 6.511.754
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -134 13.376 -0,99 492,45 -65.988 6.587.011
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -70 13.510 -0,52 491,65 -34.416 6.642.192
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -201 13.580 -1,46 489,48 -98.385 6.647.138
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -137 13.781 -0,98 488,76 -66.960 6.735.602
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3 13.918 -0,02 484,14 -1.452 6.738.261
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -124 13.921 -0,88 483,58 -59.964 6.731.917
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -62 14.045 -0,44 482,09 -29.890 6.770.954
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -58 14.107 -0,41 480,28 -27.856 6.775.310
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -69 14.165 -0,48 479,00 -33.051 6.785.035
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -63 14.234 -0,44 478,77 -30.163 6.814.812
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 1.200 14.297 9,16 30,63 36.756 437.917
2020-01-27 2020-01-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Incentive Stock Option (right to buy)
M - Exercise -500 3.380 -12,89
2020-01-27 2020-01-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 500 13.097 3,97 30,63 15.315 401.161
2019-12-23 2019-12-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Incentive Stock Option (right to buy)
M - Exercise -400 3.880 -9,35
2019-12-23 2019-12-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 400 12.597 3,28 30,63 12.252 385.846
2019-12-13 2019-12-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -51 12.197 -0,42 378,27 -19.292 4.613.759
2019-12-13 2019-12-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -346 12.248 -2,75 377,38 -130.573 4.622.150
2019-12-13 2019-12-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -470 12.594 -3,60 376,27 -176.847 4.738.744
2019-12-13 2019-12-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -624 13.064 -4,56 375,58 -234.362 4.906.577
2019-12-13 2019-12-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -191 13.688 -1,38 374,82 -71.591 5.130.536
2019-12-13 2019-12-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -3.100 7.226 -30,02
2019-12-13 2019-12-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes X -1.418 13.879 -9,27 377,16 -534.813 5.234.604
2019-12-13 2019-12-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 3.100 15.297 25,42 52,03 161.293 795.903
2019-12-13 2019-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
A - Award 6.120 6.120
2019-12-13 2019-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 2.500 12.197 25,78
2019-12-13 2019-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 1.020 9.697 11,76
2019-04-18 2019-04-18 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -350 0 -100,00
2019-04-18 2019-04-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift 350 1.897 22,62
2019-04-18 2019-04-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift -350 7.096 -4,70
2019-04-18 2019-04-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 350 7.446 4,93 21,25 7.438 158.228
2019-01-18 2019-01-18 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -150 350 -30,00
2019-01-18 2019-01-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift 150 1.547 10,74
2019-01-18 2019-01-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift -150 7.096 -2,07
2019-01-18 2019-01-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 150 7.246 2,11 21,25 3.188 153.978
2018-12-20 2018-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -675 500 -57,45
2018-12-20 2018-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -200 7.096 -2,74 362,45 -72.490 2.571.945
2018-12-20 2018-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -100 7.296 -1,35 361,65 -36.165 2.638.598
2018-12-20 2018-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -500 7.396 -6,33 360,40 -180.200 2.665.518
2018-12-20 2018-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -200 7.896 -2,47 359,38 -71.876 2.837.664
2018-12-20 2018-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -200 8.096 -2,41 358,27 -71.654 2.900.554
2018-12-20 2018-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -200 8.296 -2,35 357,50 -71.500 2.965.820
2018-12-20 2018-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -348 8.496 -3,93 356,27 -123.982 3.026.870
2018-12-20 2018-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -100 8.844 -1,12 355,14 -35.514 3.140.858
2018-12-20 2018-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 675 8.944 8,16 21,25 14.344 190.060
2018-12-20 2018-12-19 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -3.450 10.326 -25,04
2018-12-20 2018-12-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -1.602 8.269 -16,23 364,42 -583.801 3.013.389
2018-12-20 2018-12-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 3.450 9.871 53,73 52,03 179.504 513.588
2018-12-14 2018-12-12 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 11.400 11.400
2018-12-14 2018-12-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
A - Award 5.000 6.421 351,86
2018-12-14 2018-10-25 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift 2.950 2.950
2018-12-14 2018-10-25 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift -2.950 1.397 -67,86
2018-12-14 2018-08-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift 50 4.347 1,16
2018-12-14 2018-08-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift -50 1.421 -3,40
2018-08-31 2018-08-30 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -50 1.175 -4,08
2018-08-31 2018-08-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 50 200 33,33 21,25 1.062 4.250
2018-01-17 2018-01-16 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -150 1.225 -10,91
2018-01-17 2018-01-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 150 150 21,25 3.188 3.188
2017-12-13 2017-12-12 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 12.300 12.300
2017-03-02 3 REGN REGENERON PHARMACEUTICALS INC
Common Stock
9.648
2017-03-02 3 REGN REGENERON PHARMACEUTICALS INC
Common Stock
11.015
2017-03-02 3 REGN REGENERON PHARMACEUTICALS INC
Common Stock
12.617
2017-03-02 3 REGN REGENERON PHARMACEUTICALS INC
Common Stock
9.648
2017-03-02 3 REGN REGENERON PHARMACEUTICALS INC
Common Stock
11.015
2017-03-02 3 REGN REGENERON PHARMACEUTICALS INC
Common Stock
12.617
P
Piața deschisă sau achiziția privată de titluri nederivate sau derivate
S
Piața deschisă sau vânzarea privată a titlurilor de valoare nederivate sau derivate
A
Acordarea, atribuirea sau alte achiziții de valori mobiliare de la companie (cum ar fi o opțiune)
C
Conversia derivatei
D
Vânzarea sau transferul de valori mobiliare înapoi către companie
F
Plata prețului de exercițiu sau a obligației fiscale folosind o parte din titlurile de valoare primite de la companie
G
Donarea de valori mobiliare de către sau către persoane din interior
K
Swap-uri de acțiuni și tranzacții similare de acoperire împotriva riscurilor
M
Exercitarea sau conversia titlurilor derivate primite de la companie (cum ar fi o opțiune)
V
O tranzacție raportată voluntar pe Formularul 4
J
Altele (însoțite de o notă de subsol care descrie tranzacția)